摘要: |
目的:基于美国不良事件数据库进行分析,挖掘超声造影剂六氟化硫(SonoVue)的药品不良事件信号,为临床安全用药提供参考。
方法:提取 FAERS 数据库2015年至2023年所有上报的SonoVue药物不良事件报告(Adverse Drug Event,ADE),采用报告比值比(ROR)法、比例报告比值比(PRR)法和BCPNN法对ADE进行分析,获得真实世界发生的ADE,并发掘药品说明书未标注的ADE。
结果:共提取12178164份来自FAERS数据库的不良事件报告。其中SonoVue被确定为首要可疑药物的ADE为1079份。患者性别以男性为主(56.35%),上报国籍以美国为主(86.28%)。导致的ADE主要针对16个系统器官分类,以各类神经系统疾病、全身性疾病及给药部位各种反应、呼吸系统、免疫系统疾病及心脏器官疾病为主,ADE风险信号与药品说明书基本一致。同时发掘到了说明书未收录的不良反应,包括眼器官疾病(ROR=0.61)、肾脏及泌尿系统疾病(ROR=0.36),耳及迷路类疾病(ROR=7.2),感染及侵染类疾病(ROR= 0.03),但是高风险信号较低。严重ADE结局多为危及生命(23.2%)及住院治疗(23.04%),存在4.69%的死亡ADE报告情况。
结论:超声造影剂六氟化硫微泡较为安全,实际应用存在部分说明书未收录不良反应,建议临床实际应用过程中应严格把握禁忌症、注意事项及加强监护。 |
关键词: 六氟化硫 FAERS数据库 药品不良事件 信号挖掘 |
DOI: |
投稿时间:2024-03-27修订日期:2024-06-07 |
基金项目:广东省医学科学技术研究(B2021148);湛江市非资助课题(200722114920577) |
|
Signal mining of post-marketing adverse drug events for the ultrasound contrast agent sulphur hexafluoride (SonoVue) based on the FAERS database |
linxian,Chen xuesong,Liu lijuan,Ren ran,Xu xiaohong |
(Affiliated Hospital of Guangdong Medical University) |
Abstract: |
OBJECTIVE: To conduct an analysis based on the U.S. Adverse Event Database (FAERS) to mine the adverse drug event signals of the ultrasound contrast agent sulphur hexafluoride (SonoVue) for safe clinical use.
METHODS: All reported SonoVue adverse drug event reports (ADEs) from 2015 to 2023 in the FAERS database were extracted, and the ADEs were analysed using the report-to-ratio (ROR) method, the proportionate report-to-ratio (PRR) method, and the BCPNN method, to obtain ADEs occurring in the real world and to uncover ADEs whose drug ADEs that were not labelled in the specification.
RESULTS: A total of 12,178,164 adverse event reports from the FAERS database were extracted. Of these ADEs, SonoVue was identified as the first suspected drug in 1079 ADEs. Patient gender was predominantly male (56.35%) and reported nationality was predominantly American (86.28%). The resulting ADEs were mainly for 16 system-organ classifications, with various neurological disorders, systemic disorders and various reactions at the site of administration, respiratory system, immune system disorders, and cardiac organ disorders being the main ones, and the ADE risk signals were generally consistent with the drug inserts. Adverse reactions not included in the specification, including eye organ diseases (ROR=0.61), renal and urinary system diseases (ROR=0.36), ear and labyrinthine disorders (ROR=7.2), and infections and invasive diseases (ROR=0.03), were also discovered, but the high risk signals were low. Severe ADE outcomes were mostly life-threatening (23.2%) and hospitalisation (23.04%), and there were 4.69% of fatal ADEs reported.
CONCLUSION: Sulfur hexafluoride microbubbles, an ultrasound contrast agent, are relatively safe, and the actual application of some of the instructions are not included in the adverse reactions, and it is recommended that contraindications, precautions, and supervision should be strictly grasped in the process of actual clinical application. |
Key words: sulfur hexafluoride FAERS database adverse drug events signal mining |